High recurrent rate of multicentric papillary thyroid carcinoma

Annals of Surgical Oncology

Volumn 16, Issue 9, 2009, Pages 2609-2616

  Lin, Jen Der ^a   Chao, Tzu Chieh ^a   Hsueh, Chuen ^a   Kuo, Sheng Fong ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOACTIVE IODINE; THALLIUM 201;

ADJUVANT THERAPY; ADULT; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; PAPILLARY CARCINOMA; POSTOPERATIVE CARE; RECURRENCE RISK; RECURRENT CANCER; SURVIVAL RATE; THYROID CARCINOMA; THYROIDECTOMY;

ADENOCARCINOMA, FOLLICULAR; ADULT; CARCINOMA, PAPILLARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 68949204938     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0565-7     Document Type: Article

References (30)

1. TP Links KM van Tol PL Jager JT Plukker DA Piers HM Boezen et al 2005 Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis Endocr Relat Cancer 12 273 280
2. Y Cheema D Repplinger D Elson H Chen 2006 Is tumor size the best predictor of outcome for papillary thyroid cancer? Ann Surg Oncol 13 1524 1528
3. TH Low L Delbridge S Sidhu D Learoyd B Robinson P Roach et al 2008 Lymph node status influences follow-up thyroglobulin levels in papillary thyroid cancer Ann Surg Oncol 15 2827 2832
4. R Giannini C Ugolini C Lupi A Proietti R Elisei G Salvatore et al 2007 The heterogenous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma J Clin Endocrinol Metab 92 3511 3516
5. Sobin LH, UICC (2002) Wittekind Ch, editor. TNM classification of malignant tumors. 6th ed. New York: Wiley-Liss; 2002. p. 52-6.
6. JD Lin SF Kuo TC Chao C Hsueh 2008 Incidental and nonincidental papillary thyroid microcarcinoma Ann Surg Oncol 15 2287 2292
7. Delellis RA, Lloyd RV, Heitx PU, Eng C. Pathology and genetics of tumors of endocrine organs. In: World health organization of tumours. Lyon: IARC; 2004. p. 73-6.
8. DD Zhang XH Zhou DH Freeman JL Freeman 2002 A non-parametric method for the comparison of partial areas under ROC curves and its application to large health care data sets Stat Med 21 701 715
9. D Simonowitz S Thomsen AR Moossa GE Block 1976 The treatment of incidental papillary thyroid cancer Arch Surg 111 477 483
10. M Miyaki T Iijima R Ishii T Hishima T Mori K Yoshinaga et al 2000 Molecular evidence for multicentric development of thyroid carcinomas in patients with familial adenomatous polyposis Am J Pathol 157 1825 1827
11. PL Gerfo J Chabot P Gazetas 1990 The intraoperative incidence of detectable bilateral and multicentric disease in papillary cancer of the thyroid Surgery 108 958 962
12. E Kebebew 2008 Hereditary non-medullary thyroid cancer World J Surg 32 678 682
13. SS Stoffer DL Van Dyke JV Bach W Szpunar L Weiss 1986 Familial papillary carcinoma of the thyroid Am J Med Genet 25 775 782
14. Y Yamamoto T Maeda K Izumi H Otsuka 1990 Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases Cancer 65 1173 1179
15. ST Aherne PC Smyth RJ Flavin SM Russell KM Denning JH Li et al 2008 Geographic mapping of a multifocal thyroid tumour using genetic alteration analysis & miRNA profiling Mol Cancer 7 89
16. X Lee M Gao Y Ji Y Yu Y Feng Y Li et al 2009 Analysis of differential BRAF(V600E) mutation status in high aggressive papillary thyroid microcarcinoma Ann Surg Oncol 16 240 245
17. C Lupi R Giannini C Ugolini A Proietti P Berti M Minuto et al 2007 Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma J Clin Endocrinol Metab 92 4085 4090
18. V Rodolico D Cabibi G Pizzolanti P Richiusa N Gebbia A Martorana et al 2007 BRAF (V600E) mutation and p27 (kip1) expression in papillary carcinomas of the thyroid
19. TY Kim WB Kim JY Song YS Rhee G Gong YM Cho et al 2005 The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma Clin Endocrinol 63 588 593
20. V Trovisco P Soares A Preto IV de Castro J Lima P Castro et al 2005 Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness Virchows Arch 446 589 595
21. FJ Martinez-Tello R Martinez-Cabruja J Fernandez-Martin C Lasso-Oria C Ballestin-Carcavilla 1993 Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods Cancer 71 4022 4029
22. AW Furmanchuk N Roussak C Ruchti 1993 Occult thyroid carcinomas in the region of Minsk, Belarus. An autopsy study of 215 patients Histopathology 23 319 325
23. A Toniato IM Boschin A Piotto MR Pelizzo A Guolo M Foletto et al 2008 Complications in thyroid surgery for carcinoma: one institution's surgical experience World J Surg 32 572 575
24. JM Stulak CS Grant DR Farley GB Thompson JA van Heerden ID Hay et al 2006 Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer Arch Surg 141 489 494
25. A Frilling R Görges K Tecklenborg P Gassmann M Bockhorn M Clausen CE Broelsch 2000 Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma Surgery 128 1067 1074
26. L Seiboth D Van Nostrand L Wartofsky Y Ousman J Jonklaas C Butler et al 2008 Utility of PET/neck MRI digital fusion images in the management of recurrent or persistent thyroid cancer Thyroid 18 103 111
27. L Giovanella L Ceriani A Ghelfo F Keller 2005 Thyroglobulin assay 4 weeks after thyroidectomy predicts outcome in low-risk papillary thyroid carcinoma Clin Chem Lab Med 43 843 847
28. S Bardet E Malville JP Rame E Babin G Samama D De Raucourt et al 2008 Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma Eur J Endocrinol 158 551 560
29. M Perrino G Vannucchi L Vicentini G Cantoni D Dazzi C Colombo et al 2009 Outcome predictors and impact of central node dissection and radiometabolic treatment in papillary thyroid cancers <=2 cm Endocr Relat Cancer 16 201 210
30. S Noguchi H Yamashita S Uchino 2009 Modified radical neck dissection is better than partial dissection of lymph nodes World J Surg 33 394 396